Cagrilintide

10 × 10mg

A long-acting amylin analog. Studied as a satiety-signaling adjunct to GLP-1 agonists for compound weight-management and appetite-regulation research.

$690.00

$483.00

Save $207.00

Pay for 7 vials, receive 10 — $48.30 per vial instead of $69.00.

Every pack earns rewards points · free shipping over $100

Buy a single vial Research guide

About Cagrilintide

Cagrilintide is a once-weekly amylin analog originally developed as a companion to semaglutide. Amylin is co-secreted with insulin by pancreatic β-cells and signals satiety through the area postrema — a mechanism parallel to but distinct from GLP-1. Why the dual-mechanism matters: GLP-1 agonists act on hypothalamic nuclei; amylin acts on the brainstem. Published research pairing the two shows additive — sometimes synergistic — effects on food intake and body-weight endpoints. IF the research question is maximal appetite suppression with complementary pathways, THEN the amylin + GLP-1 pairing (CagriSema-style) is where the current metabolic literature is concentrated. SO Cagrilintide belongs in any study comparing mono- versus dual-agonist weight-regulation. Lyophilized, ≥99% purity, CoA-verified.

Specifications

CAS number: 1415456-99-3
Molecular formula: C194H304N54O61
Molecular weight: 4388.10 g/mol
Purity: >99% HPLC
Form: Lyophilized powder
Storage: Store at 2–8°C

For laboratory research use only. Not for human or veterinary use.